Answers are grounded in this paper and cite their sources.
De novo missense variants in HDAC3 cause a variable neurodevelopmental disorder. However, previously reported variants produced overlapping abnormalities in catalytic activity, corepressor interactions, and nuclear localization, obscuring the contribution of individual HDAC3 functions. We identified a de novo HDAC3 variant, NM_003883.4:c.403C > A, p.(His135Asn), in a girl with infantile epileptic spasms syndrome and profound developmental impairment. The HDAC3 H135N substitution replaces the second histidine of the conserved H134–H135 catalytic motif within the HDAC3 active center and is spatially separated from the principal NCoR/SMRT deacetylase-activating domain (DAD) interface. In HEK293T cells, variant HDAC3 showed steady-state abundance and nuclear enrichment comparable to wild type, and NCoR1, NCoR2/SMRT, and CoREST/RCOR1 were detectable in immunoprecipitates from both wild-type and H135N samples under the tested conditions, with no overt difference. By contrast, HDAC3-associated deacetylase activity was reduced, with increased H3K9ac and H3K27ac signals but no significant change in pan-H3ac. These findings are consistent with a catalysis-predominant defect under the conditions examined, without marked changes in HDAC3 abundance, nuclear enrichment, or detectable association with the tested corepressors. Together with previously reported variants, this case suggests that severe HDAC3-related neurodevelopmental impairment may occur in the absence of primary microcephaly.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: